Release Date: 13/07/10 15:58 Summary: One Investment Group - Implementation Deed signed Price Sensitive: Yes Download Document 28.95KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%